Results 91 to 100 of about 75,726 (102)

Chimeric antigen receptor T-cell therapies for lymphoma

Nature Reviews Clinical Oncology, 2017
Jennifer N Brudno, James N Kochenderfer, Brudno Jennifer N   +2 more
exaly  

Tumor control versus adverse events with targeted anticancer therapies

Nature Reviews Clinical Oncology, 2011
Dorothy M Keefe, Keefe Dorothy M K
exaly  

An accelerated pathway for targeted cancer therapies

Nature Reviews Drug Discovery, 2011
Stephen H Friend, Mcclellan Mark, Epstein David   +2 more
exaly  

The evolving landscape of tissue‐agnostic therapies in precision oncology

Ca-A Cancer Journal for Clinicians
Vivek Subbiah, Mohamed A Gouda, Bettina Ryll   +2 more
exaly  

Systemic treatment of soft-tissue sarcoma—gold standard and novel therapies

Nature Reviews Clinical Oncology, 2014
Mark Linch, Aisha B Miah, Khin Thway
exaly  

GROWING INTEREST IN COMPLEMENTARY AND ALTERNATIVE CANCER THERAPIES

Ca-A Cancer Journal for Clinicians, 2004
exaly  

New therapies and standard of care in oncology

Nature Reviews Clinical Oncology, 2011
V T Devita, George P Canellos, Devita Vincent T   +2 more
exaly  

HER2-targeted therapies — a role beyond breast cancer

Nature Reviews Clinical Oncology, 2019
Do-Youn Oh, Yung-Jue Bang, Oh Do-Youn
exaly  

Alternative Therapies for Curing Cancer: What Do Patients Want? What Do Patients Need?

Ca-A Cancer Journal for Clinicians, 2001
exaly  

Personalizing therapies over the course of hormone receptor‐positive/HER2‐negative metastatic breast cancer

Ca-A Cancer Journal for Clinicians
Akshara Singareeka Raghavendra, Senthil Damodaran, CARLOS H Barcenas   +2 more
exaly